Case Studies, Pharmaceutical

Case Study – The Airless+ Dermal Drug Delivery System

Discontinuation of a critical dispensing device or component from the supply chain can lead to costly stock out situations for product owners and negative health impacts for patients.

This case describes how Aptar Pharma was able to rapidly help a customer transition to an optimal off-the-shelf gel dispensing device, Airless+ ES, that seamlessly replaced their discontinued dispensing system, providing equivalent dosing precision with the original product formulation. Aptar Pharma quickly identified an Airless+ ES dermal dispensing system that met their specific product’s dose weight, fill volume parameters and regulatory requirements.

Combined with Aptar Pharma’s unique Extended Support (ES) offering that included compatibility and functionality testing (FAPT), product specific performance data studies, relevant USP/ISO testing and material selection data, Aptar Pharma provided complete services all backed by comprehensive regulatory support compliant with drug-device combination regulations (European MDR 2017/745 and U.S. FDA 21CFR820.30).

Aptar Pharma was able to derisk the customer’s transition to a new gel dispensing solution, that offered secure device supply, and comprehensive development and support services that allowed Aptar Pharma to meet critical customer timelines and avoid costly product stock-outs.

Download Free Airless+ Dermal Drug Delivery System Case Study
6 Jul 2023

Learn more about Airless+ Dermal Drug Delivery Systems

Find Out More about Airless+ Dermal Drug Delivery Systems

This Might Also Be of Interest

18 Dec 2023

Elevating Medication Adherence and Clinical Outcomes with Connected Drug Delivery

Publications, Pharmaceutical, Product Solutions, Device Innovations, Brand Differentiation, Market Insights

Read More
6 Jul 2023

Case Study – The Airless+ Dermal Drug Delivery System

Case Studies, Pharmaceutical, Sustainability, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
5 Apr 2023

De-risking Combination Product Registration for Semi-solids with Aptar Pharma Airless...

Publications, Pharmaceutical, Sustainability, Device Innovations, Market Insights, Product Solutions

Read More
13 Mar 2023

Moving Towards Greater Recyclability in Drug Delivery – Sustainable Solutions b...

Webinars, Pharmaceutical, Market Insights, Product Solutions, Sustainability, Device Innovations, Brand Differentiation

Read More
1 2 3 5

Request Access

Close

Requesting access to Case Study – The Airless+ Dermal Drug Delivery System.

  • This field is for validation purposes and should be left unchanged.
Back To Top